Temporal dynamics of Human mastadenovirus species in cases of respiratory illness in southern Brazil.
HAdV-D
HAdV-E
Human mastadenovirus
Nested PCR
Respiratory infections
Journal
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
ISSN: 1678-4405
Titre abrégé: Braz J Microbiol
Pays: Brazil
ID NLM: 101095924
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
10
01
2019
accepted:
12
04
2019
pubmed:
29
4
2019
medline:
22
11
2019
entrez:
29
4
2019
Statut:
ppublish
Résumé
Human mastadenovirus (HAdV) genus is related to several diseases, among them upper and lower respiratory tract illness. HAdV species B, C, D, and E are mainly associated with respiratory infections. The goal of this work was to identify the HAdV species associated with respiratory infections in hospitalized patients from southern Brazil. Samples were collected from 1996 to 2004 and 2011 to 2017. During this period, 28,524 samples were collected, and 9983 were positive for respiratory viruses, being 435 for HAdV. From these 435 samples, 57 were selected for characterization of HAdV species. For screening the presence of HAdV, a partial sequence of the DNA polymerase gene (DNApol gene) was amplified by nested PCR. Partial nucleotide sequencing was performed in positive samples, and HAdV (DNApol gene) was detected in 53 samples: species B (28; 49.1%), C (16; 28.0%), D (2; 3.5%), E (5; 8.7%), and untyped (2; 3.5%). Specie D was found only in 2017 and specie E in 2011 and 2012. The age of the patients ranged from < 1 to 81 years old, and 62.3% were male. No relationship between gender or age and identified HAdV species were observed. In addition, in the period of 2013-2017, 18 samples from patients who died were analyzed: 11 were related to species B, 4 to C, and 2 to D and 1 remained untyped. Circulation of HAdV species D and E varied over the years, but species B and C were present throughout the evaluated period. In addition, respiratory infections by HAdV affect elderly and children mainly.
Identifiants
pubmed: 31030411
doi: 10.1007/s42770-019-00084-4
pii: 10.1007/s42770-019-00084-4
pmc: PMC6863322
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
677-684Subventions
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
ID : 402023/2016-1
Commentaires et corrections
Type : ErratumIn
Références
J Glob Health. 2015 Jun;5(1):010408
pubmed: 26445672
Infect Control Hosp Epidemiol. 2010 Jul;31(7):755-7
pubmed: 20509762
Clin Infect Dis. 2006 Aug 1;43(3):331-9
pubmed: 16804849
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
J Virol. 2010 Apr;84(8):3889-97
pubmed: 20089640
J Mol Evol. 1980 Dec;16(2):111-20
pubmed: 7463489
PLoS One. 2016 May 12;11(5):e0155412
pubmed: 27171486
Jpn J Infect Dis. 2014;67(2):105-10
pubmed: 24647252
Virol J. 2011 Jan 18;8:23
pubmed: 21241515
Epidemiol Infect. 2016 Jan;144(2):355-62
pubmed: 26112312
Virus Res. 2009 Jan;139(1):122-6
pubmed: 19000724
J Microbiol Immunol Infect. 2017 Aug;50(4):418-426
pubmed: 26454422
PLoS One. 2013;8(1):e53614
pubmed: 23326469
PLoS One. 2016 Apr 05;11(4):e0152375
pubmed: 27045588
J Med Virol. 2007 Feb;79(2):174-81
pubmed: 17177301
Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
J Med Virol. 2010 Apr;82(4):624-31
pubmed: 20166176
Emerg Infect Dis. 2016 Jun;22(6):1044-51
pubmed: 27191834
Paediatr Respir Rev. 2007 Dec;8(4):275-80
pubmed: 18005894
Mol Biol Evol. 2011 Oct;28(10):2731-9
pubmed: 21546353